MA
CLVS

MUFG Americas’s Clovis Oncology, Inc. CLVS Stock Holding History

MUFG Americas’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-401
Closed -$18K – 861
2018
Q2 		$18K Hold
401
– – ﹤0.01% 678
2018
Q1 		$21K Sell
401
-121
-23% -$7.06K ﹤0.01% 653
2017
Q4 		$35K Buy
522
+10
+2% +$699 ﹤0.01% 633
2017
Q3 		$42K Buy
512
+11
+2% +$872 ﹤0.01% 597
2017
Q2 		$47K Hold
501
– – ﹤0.01% 579
2017
Q1 		$32K Buy
501
+90
+22% +$5.47K ﹤0.01% 636
2016
Q4 		$18K Buy
+411
New +$14.5K ﹤0.01% 740

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

MUFG Americas's CLVS Position: Q3 2018 in Review

MUFG Americas sold out of Clovis Oncology, Inc. (CLVS) in Q3 2018, closing a stake of 401 shares — an estimated $18K sold.

MUFG Americas first reported a position in CLVS in Q4 2016 and held it in 7 quarters. The position peaked at $47K in Q2 2017. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2018.

  • MUFG Americas reported no remaining Clovis Oncology, Inc. position as of Q3 2018 after selling out during the quarter.
  • MUFG Americas sold 401 Clovis Oncology, Inc. shares in Q3 2018, an estimated $18K.
  • MUFG Americas first reported a position in Clovis Oncology, Inc. in Q4 2016 and held it in 7 quarters.
  • MUFG Americas's Clovis Oncology, Inc. position peaked at $47K in Q2 2017.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2018.

Based on MUFG Americas's 13F filing for Q3 2018, filed 14 Nov 2018.